Department of Sports Medicine, the Affiliated Hospital of Qingdao University, Shandong Qingdao, 266000, China.
Department of Traumatology, the Affiliated Hospital of Qingdao University, Shandong Qingdao, 266000, China.
BMC Musculoskelet Disord. 2024 Jul 5;25(1):518. doi: 10.1186/s12891-024-07639-z.
The practice of simultaneous bilateral unicompartmental knee arthroplasty (SBUKA) remains a topic of debate, particularly in patients with obesity. Thus, the purpose of this study was to assess the impact of body mass index (BMI) on the 30-day complication rate and the survival rate of the implant following SBUKA.
We retrospectively examined the clinical records of 245 patients (490 knees) who underwent SBUKA at the Affiliated Hospital of Qingdao University and the Third Hospital of Hebei Medical University between January 2010 and December 2020. Patients were categorised based on their BMI at the time of surgery into four groups: normal weight (BMI 18.5 to 22.9 kg/m), overweight (BMI 23.0 to 24.9 kg/m), obese (BMI 25.0 to 29.9 kg/m), and severely obese (BMI ≥30 kg/m). Variables such as length of hospital stay, duration of surgery, and costs of hospitalisation were compared across all groups. Additionally, we recorded the 30-day postoperative complication rate and the time from surgery to any required revision. The Kaplan-Meier survival analysis was employed to evaluate and compare the implant survival rates.
The follow-up period for the 245 patients ranged from 39 to 114 months, with an average of 77.05±18.71 months. The incidence of complications within 30 days post-surgery did not significantly differ across the groups (χ2 = 1.102, p = 0.777). The implant survival rates from the lowest to the highest BMI groups were 97.14%, 93.9%, 94.44%, and 96.43%, respectively. Both the rate of implant revision (χ2 =1.612, p = 0.657) and the survival curves of the implants (p = 0.639) showed no statistically significant differences among the groups.
BMI did not influence the 30-day complication rate nor the survival rate of implants following SBUKA, suggesting that SBUKA should not be contraindicated based on BMI alone.
同期双侧单髁膝关节置换术(SBUKA)的实践仍然存在争议,尤其是在肥胖患者中。因此,本研究旨在评估体重指数(BMI)对 SBUKA 后 30 天并发症发生率和植入物存活率的影响。
我们回顾性分析了 2010 年 1 月至 2020 年 12 月期间在青岛大学附属医院和河北医科大学第三医院接受 SBUKA 的 245 例患者(490 膝)的临床记录。根据手术时的 BMI 将患者分为四组:正常体重(BMI 18.5 至 22.9kg/m)、超重(BMI 23.0 至 24.9kg/m)、肥胖(BMI 25.0 至 29.9kg/m)和重度肥胖(BMI≥30kg/m)。比较所有组之间的住院时间、手术持续时间和住院费用等变量。此外,我们记录了 30 天术后并发症发生率和从手术到任何必要翻修的时间。采用 Kaplan-Meier 生存分析评估和比较植入物的存活率。
245 例患者的随访时间为 39 至 114 个月,平均 77.05±18.71 个月。术后 30 天内并发症的发生率在各组之间无显著差异(χ2=1.102,p=0.777)。从最低 BMI 组到最高 BMI 组的植入物存活率分别为 97.14%、93.9%、94.44%和 96.43%。植入物翻修率(χ2=1.612,p=0.657)和植入物生存曲线(p=0.639)均无统计学差异。
BMI 不影响 SBUKA 后 30 天内的并发症发生率和植入物的存活率,这表明不应仅根据 BMI 来禁忌 SBUKA。